Infection Surveillance Solution Market - Global Forecast 2025-2032

The infection surveillance solution market is undergoing rapid advancement, driven by healthcare organizations seeking robust digital tools for improved compliance, operational efficiency, and risk management across diverse clinical environments.

Market Snapshot: Infection Surveillance Solution Market Growth

The global infection surveillance solution market is on a notable upward trajectory, with revenue expanding from USD 867.99 million in 2024 to USD 985.81 million by 2025 and demonstrating a 13.80% compound annual growth rate. Looking further ahead, forecasts indicate the sector could reach USD 2.44 billion by 2032. This acceleration is closely tied to heightened investment in digital infection detection and prevention among healthcare providers. Senior decision-makers are prioritizing real-time analytics and adaptive platforms to navigate evolving regulatory demands, optimize workflows, and reinforce organizational resilience amid complex operational landscapes.

Scope & Segmentation of the Infection Surveillance Solution Market

A comprehensive segmentation approach shapes strategic investments, procurement plans, and technology adoption for healthcare executives and procurement leaders. Each segment responds to distinct organizational priorities, regulatory requirements, and regional characteristics associated with infection surveillance solution deployments:

• Component: Consulting, implementation, integration, maintenance, upgrades, and training services underpin effective migration to new surveillance systems and ensure ongoing compliance support.
• Deployment Mode: Cloud-based (public, private, hybrid) and on-premises options offer flexible alignment with IT infrastructure, data governance standards, and organizational growth objectives.
• Technology: Artificial intelligence, machine learning, Internet of Things, and rule-based analytics empower timely detection of infection patterns, supporting preemptive resource deployment and enhanced clinical decision-making.
• Application: Infection prevention, healthcare-associated surveillance, outbreak management, contact tracing, genomic and syndromic monitoring enrich response capabilities across a spectrum of clinical and public health environments.
• End User: Hospitals, diagnostic laboratories, research institutions, and public health agencies benefit from tailored workflow integration and streamlined regulatory reporting.
• Regions: Americas, Europe, Middle East, Africa, and Asia-Pacific demonstrate differentiated adoption paces influenced by regional digital health practices and policy landscapes.

Key industry participants such as Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Abbott Laboratories, Siemens Healthineers AG, Sysmex Corporation, Bio-Rad Laboratories, QIAGEN N.V., and Agilent Technologies propel market progress by investing in innovative and scalable infection surveillance platforms.

Key Takeaways for Senior Decision-Makers

• Selecting between cloud-based or on-premises deployment enables organizations to match integration strategies to security requirements and infrastructure resources.
• Incorporating artificial intelligence and machine learning fosters advanced predictive modeling, supporting proactive and preventative infection control initiatives.
• Partnering with vendors offering full lifecycle support—including consulting and ongoing assistance—ensures smoother adaptation to rapidly changing regulatory standards.
• Mobile-enabled and interoperable features in modern platforms simplify integration with existing clinical workflows and bolster consistent compliance.
• Scaling solutions alongside organizational needs encourages readiness in managing new infection risks, supporting long-term operational sustainability and resilience.

Tariff Impact and Procurement Strategies

Anticipated U.S. tariffs on imported medical software and devices in 2025 are prompting organizations to optimize procurement strategies. Healthcare operators are assessing regional suppliers, considering nearshoring, and implementing risk-sharing procurement models to strengthen supply chain integrity. These measures foster greater transparency and continuity as global trade conditions evolve, reducing operational risk and supporting ongoing access to infection surveillance solution technology.

Methodology & Data Sources

This analysis integrates data from structured interviews with healthcare epidemiologists, diagnostic laboratory leaders, and infection surveillance solution vendors. Validation comes from compliance audits, published literature reviews, and pilot project evaluations, ensuring recommendations address operational realities and sector-specific priorities.

Why This Report Matters

• Delivers actionable insights for integrating infection surveillance solutions into evolving procurement and IT compliance strategies during digital transformation.
• Empowers executive teams to make informed vendor and technology decisions for adaptive risk management in dynamic healthcare environments.
• Provides benchmarking tools and clear guidance to support operational improvements in diverse healthcare delivery frameworks, advancing performance and resilience.

Conclusion

Infection surveillance solutions are vital for leaders seeking flexible, resilient, and compliant operational models as digital technologies and regulations transform the healthcare landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.